Allograft For Degenerative Disease
A new cervical allograft is the first that can be stored at room temperature in a fully hydrated state.
November 20, 2009
DePuy Spine, Inc., expands its portfolio for degenerative disease with the launch of the VERTIGRAFT® VG2® Cervical Allograft with PRESERVON® Technology, the first allograft that can be stored at room temperature in a fully hydrated state. According to the company, the VERTIGRAFT VG2 Cervical Allograft with PRESERVON Technology features:
- A composite of cortical and cancellous bone.
- PRESERVON, a new, proprietary glycerol-based preservation solution developed by LifeNet Health® and exclusive to DePuy Spine, that eliminates the need to freeze or freeze-dry the allograft and avoids the lengthy thawing and rehydration process, which saves time in the operating room.
For more information, visit www.depuy.com